Capitolis Liquid Global Markets’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.1M Sell
154,998
-18,777
-11% -$1.45M 0.07% 171
2025
Q4
$13.8M Buy
173,775
+23,775
+16% +$1.87M 0.08% 133
2025
Q3
$11.3M Buy
+150,000
New +$10.3M 0.09% 129
2025
Q2
Sell
-381,000
Closed -$25.8M 264
2025
Q1
$25.8M Buy
+381,000
New +$22.8M 0.23% 72
2024
Q2
Sell
-116,000
Closed -$9.25M 114
2024
Q1
$9.25M Hold
116,000
0.15% 85
2023
Q4
$9.16M Buy
+116,000
New +$8.26M 0.38% 47

Other funds holding CVS

Capitolis Liquid Global Markets's CVS Position: Q1 2026 in Review

Capitolis Liquid Global Markets reduced its CVS Health (CVS) stake by 11% in Q1 2026, selling an estimated $1.45M and leaving 154,998 shares worth $11.1M. The position accounts for 0.07% of the portfolio, ranked #171.

Capitolis Liquid Global Markets first reported a position in CVS in Q4 2023 and has held it in 6 quarters since. The position peaked at $25.8M in Q1 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Capitolis Liquid Global Markets held 154,998 shares of CVS Health worth $11.1M as of Q1 2026.
  • Capitolis Liquid Global Markets sold 18,777 CVS Health shares in Q1 2026, an estimated $1.45M.
  • CVS Health made up 0.07% of Capitolis Liquid Global Markets's portfolio in Q1 2026, its #171 holding.
  • Capitolis Liquid Global Markets first reported a position in CVS Health in Q4 2023 and has held it in 6 quarters since.
  • Capitolis Liquid Global Markets's CVS Health position peaked at $25.8M in Q1 2025.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q1 2026, filed 15 May 2026.